American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
NE
Nexentis Technologies Inc.
$4.2MMarket cap
$210.0KRevenue · FY2024
-$4.0MNet income
9Employees
NXTSNASDAQ
2009IPO
About Nexentis Technologies Inc.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2024
- $210.0K
- Net income
- -$4.0M
- Total assets
- $20.4M
- Market cap
- $4.2M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $4.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 15, 2009
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Nexentis Technologies Inc..
Write a review
Explore
Browse all →
